These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37006460)

  • 1. Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review.
    Pinto AA; De Seze J; Jacob A; Reddel S; Yudina A; Tan K
    Ther Adv Neurol Disord; 2023; 16():17562864231154306. PubMed ID: 37006460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence.
    Ipe TS; Davis AR; Raval JS
    Front Neurol; 2021; 12():662856. PubMed ID: 34531809
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka KV
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis.
    Morales-Ruiz V; Juárez-Vaquera VH; Rosetti-Sciutto M; Sánchez-Muñoz F; Adalid-Peralta L
    Autoimmun Rev; 2022 Mar; 21(3):103019. PubMed ID: 34920107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of Therapeutic Apheresis in Neurological Disease.
    Strasser E
    Transfus Med Hemother; 2023 Apr; 50(2):88-97. PubMed ID: 37066058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology.
    Tonev DG; Momchilova AB
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.
    Winters JL; Brown D; Hazard E; Chainani A; Andrzejewski C
    BMC Health Serv Res; 2011 May; 11():101. PubMed ID: 21575219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.
    Nieto-Aristizábal I; Vivas ÁJ; Ruiz-Montaño P; Aragón CC; Posso-Osorio I; Quiñones J; Rivillas JA; Tobón GJ
    Autoimmune Dis; 2020; 2020():3484659. PubMed ID: 32802495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
    Boedecker SC; Luessi F; Engel S; Kraus D; Klimpke P; Holtz S; Meinek M; Marczynski P; Weinmann A; Weinmann-Menke J
    J Clin Apher; 2022 Feb; 37(1):70-81. PubMed ID: 34904748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
    Kes P; Basić-Kes V; Basić-Jukić N; Demarin V
    Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders.
    Gadian J; Kirk E; Holliday K; Lim M; Absoud M
    Dev Med Child Neurol; 2017 Feb; 59(2):136-144. PubMed ID: 27900773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
    Dada MA; Kaplan AA
    Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.
    Onuoha C; Barton KD; Wong ECC; Raval JS; Rollins-Raval MA; Ipe TS; Kiss JE; Boral LI; Adamksi J; Zantek ND; Onwuemene OA
    Transfusion; 2020 Nov; 60(11):2714-2736. PubMed ID: 32812222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.